Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin vs Cefmetazole for RIRS Prophylaxis
NCT06741917Phase 4Enrolling by invitation
- Sponsor
- National Taiwan University Hospital
- Start
- Dec 2024
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levofloxacin in sepsis (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Post-operative sepsis at 2 weeks. Started Dec 2024; status: enrolling by invitation.
02
Drugs
levofloxacin
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT06741917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06741917.